Ovarian Cancer
ARIEL3: Rucaparib Maintenance in Recurrent Ovarian Cancer
Study 19: Olaparib Maintenance in Platinum-Sensitive Relapsed Ovarian Cancer
GOG 218: Bevacizumab in Front-Line Ovarian Cancer
Management of STIC in Patients Undergoing RRSO
Ovarian Borderline Tumors
GYOEDU Resident: Ovarian Cancer Surveillance and Recurrences
HIPEC in ovarian cancer
Korean HIPEC trial
The addition of HIPEC after interval cytoreductive surgery following neoadjuvant chemotherapy provided significant improvements in PFS and OS.